TY - JOUR
T1 - Correlation of airway hyper-responsiveness with obstructive spirometric indices and FEV 1 > 90% of predicted
AU - Kotti, George H.
AU - Bell, David G.
AU - Matthews, Tokunbo
AU - Lucero, Pedro F.
AU - Morris, Michael J.
PY - 2012/4
Y1 - 2012/4
N2 - BACKGROUND: Current published guidelines on spirometry interpretation suggest an elevated FVC and FEV 1 > 100% of predicted with an obstructive ratio may represent a physiological variant. There is minimal evidence whether this finding can be indicative of symptomatic airways obstruction. METHODS: Pulmonary function testing databases for a 4-year period were retrospectively reviewed. All technically adequate spirometry studies were included, based on these criteria: FEV 1 > 90% of predicted, and FEV 1/FVC below the lower limit of normal, based on 95th percentile confidence intervals. Clinical indications for testing were noted. Testing for post-bronchodilator response, lung volumes, and methacholine challenge tests were reviewed for evidence of airway hyper-responsiveness (AHR). Comparisons were made between symptomatic versus asymptomatic individuals and FEV 1 values less than or greater than 100% of predicted. RESULTS: A total of 280 studies were analyzed. During their clinical evaluation, 192 patients (69%) had post-bronchodilator spirometry recorded, 63 patients (23%) had lung volumes, and 36 patients (11%) completed methacholine challenge testing. Indications for spirometry included 193 symptomatic patients and 87 asymptomatic patients. Nearly 28% of patients with post-bronchodilator testing met criteria for AHR. No differences in AHR were found between the symptomatic and asymptomatic groups. The majority of patients (77%) with AHR had an FEV 1 < 100%, when compared to patients with an FEV 1 ≥ 100%. CONCLUSIONS: A normal FEV 1 > 90% of predicted with obstructive indices may not represent a normal physiological variant, as 28% of patients were found to have underlying AHR. These findings suggest that clinicians should evaluate for AHR, especially in symptomatic patients, even if the FEV 1 is > 90% of predicted.
AB - BACKGROUND: Current published guidelines on spirometry interpretation suggest an elevated FVC and FEV 1 > 100% of predicted with an obstructive ratio may represent a physiological variant. There is minimal evidence whether this finding can be indicative of symptomatic airways obstruction. METHODS: Pulmonary function testing databases for a 4-year period were retrospectively reviewed. All technically adequate spirometry studies were included, based on these criteria: FEV 1 > 90% of predicted, and FEV 1/FVC below the lower limit of normal, based on 95th percentile confidence intervals. Clinical indications for testing were noted. Testing for post-bronchodilator response, lung volumes, and methacholine challenge tests were reviewed for evidence of airway hyper-responsiveness (AHR). Comparisons were made between symptomatic versus asymptomatic individuals and FEV 1 values less than or greater than 100% of predicted. RESULTS: A total of 280 studies were analyzed. During their clinical evaluation, 192 patients (69%) had post-bronchodilator spirometry recorded, 63 patients (23%) had lung volumes, and 36 patients (11%) completed methacholine challenge testing. Indications for spirometry included 193 symptomatic patients and 87 asymptomatic patients. Nearly 28% of patients with post-bronchodilator testing met criteria for AHR. No differences in AHR were found between the symptomatic and asymptomatic groups. The majority of patients (77%) with AHR had an FEV 1 < 100%, when compared to patients with an FEV 1 ≥ 100%. CONCLUSIONS: A normal FEV 1 > 90% of predicted with obstructive indices may not represent a normal physiological variant, as 28% of patients were found to have underlying AHR. These findings suggest that clinicians should evaluate for AHR, especially in symptomatic patients, even if the FEV 1 is > 90% of predicted.
KW - Airway hyper-responsiveness
KW - Normal FEV
KW - Obstruction
KW - Pulmonary function testing
UR - http://www.scopus.com/inward/record.url?scp=84860510117&partnerID=8YFLogxK
U2 - 10.4187/respcare.01244
DO - 10.4187/respcare.01244
M3 - Review article
C2 - 22004588
AN - SCOPUS:84860510117
SN - 0020-1324
VL - 57
SP - 565
EP - 571
JO - Respiratory Care
JF - Respiratory Care
IS - 4
ER -